FIELD: medicine, pharmaceutics.
SUBSTANCE: the suggested composition includes compounds of natural ethers in cancer of mammalian soft tissues (including, the man), for example, in case of diseases of mammary gland. Both dosage and frequency of introduction depending upon a certain symptomatics could be decreased up to the level at which it is necessary to maintain improved level. At weakening the symptoms up to desired level one should stop therapy immediately. At any relapse of disease symptoms patients could need periodic therapy upon lasting basis.
EFFECT: higher efficiency of application.
2 cl, 3 ex, 3 tbl
Authors
Dates
2005-05-27—Published
1999-12-07—Filed